Scientific Publications and Presentations

“Is It Time for a Paradigm Shift for the Prevention of the Recurrence of Acute Urinary Retention?” by Steve Kaplan in AUA (American Urology Association) journal Urology Practice

A Model-Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk

Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open‐label, phase 2 trial

Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies, published in Medicina

Publication of Teverelix TFA Phase I data in Clinical Pharmacology in Drug Development journal

Presentation of Phase II BPH clinical trial data at AUA Congress, 2019

Presentation of phase II prostate cancer data to the 21st Annual Congress of the European Association of Urology